Clin2
NCT06977438Possibly a fitNot yet recruiting

Weight loss program for teens with obesity

Obesity, Childhood

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,020 people
Ages
12 years to 18 years
Study type
Interventional

Who can take part

  • You are between 12 and 17 years old
  • Your weight is in the top 5% for your age and sex
  • You can attend online video sessions
  • You do not have diabetes or a history of eating disorders
  • You have not used weight loss medicines recently or had weight loss surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06852391Recruiting· Phase 4
Weight loss program with or without semaglutide for teens with obesity

This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.

Hamilton, Ontario
NCT07302802Recruiting
Semaglutide for weight loss in teens with genetic obesity

This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.

Paris
NCT06575738Recruiting· Phase 1
Semaglutide for teens after weight-loss surgery

This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.

Aurora, Colorado
NCT06633783Not yet recruiting· Phase 3
Weekly shot for weight loss in adults with obesity

This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.

Xuancheng, Anhui
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT06411210Recruiting· Phase 2
Weight loss medication for young adults with type 1 diabetes

This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.

New Haven, Connecticut

Hear when a new Obesity, Childhood trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.